Sorintellis
Sorintellis helps drug developers and investors make smarter, faster portfolio and development decisions. It uses an AI-driven decision support platform built on a proprietary, multimodal clinical-trial database (TrialsBank) to assess program success probability, risk, and value. It’s a B2B SaaS platform leveraging AI and machine learning to optimize trial design, risk management, and portfolio prioritization for pharma, CROs, and life sciences investors. The solution targets the broader market by reducing development risk and accelerating therapy delivery across drug pipelines.
Sorintellis
Sorintellis helps drug developers and investors make smarter, faster portfolio and development decisions. It uses an AI-driven decision support platform built on a proprietary, multimodal clinical-trial database (TrialsBank) to assess program success probability, risk, and value. It’s a B2B SaaS platform leveraging AI and machine learning to optimize trial design, risk management, and portfolio prioritization for pharma, CROs, and life sciences investors. The solution targets the broader market by reducing development risk and accelerating therapy delivery across drug pipelines.